High-affinity agonism at the P2X7 receptor is mediated by three residues outside the orthosteric pocket

Adam C Oken1, Nicolas E Lisi1, Ipsita Krishnamurthy1

  • 1Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.

Nature Communications
|August 6, 2024
PubMed

Insights

Researchers uncovered how high-affinity agonists activate P2X7 receptors, crucial for cancer therapy. This study reveals key residues and structural details for developing targeted P2X7 cancer treatments.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biophysics

Background:

  • P2X receptors are ATP-gated ion channels regulating cellular signaling.
  • P2X7 receptor activation is implicated in cancer biology via apoptotic pathways.
  • Understanding P2X7 high-affinity activation mechanisms is critical for therapeutic development.

Purpose of the Study:

  • To elucidate the structural mechanisms underlying high-affinity activation of the P2X7 receptor.
  • To define the molecular details of the P2X7 receptor's pore architecture in its closed state.
  • To identify specific residues responsible for high-affinity agonism by BzATP.

Main Methods:

  • High-resolution cryo-electron microscopy (cryo-EM) to determine receptor structures.
  • Electrophysiological recordings to assess receptor function.
  • Direct binding assays to quantify agonist interactions.

Main Results:

  • Determined cryo-EM structures of wild-type rat P2X7 with BzATP and apo states.
  • Revealed molecular details of pore architecture and Na+ ion interaction in the closed state.
  • Identified three specific residues outside the ATP-binding site crucial for BzATP's high-affinity agonism.

Conclusions:

  • The study provides atomic-level insights into P2X7 receptor activation by high-affinity agonists.
  • Structural and functional data pave the way for developing subtype-specific P2X7 agonists.
  • These findings support the potential of P2X7 receptor modulation in cancer therapeutics.

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K